The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
* This Week in the Journal
 December 18, 2003
*
Correspondence
* Substitution for Protease Inhibitors in HIV Therapy
* Costs of Health Care Administration in the United States and Canada
* Sudden Death in Young Athletes
* Anatomy of a Diagnosis
* Myocardial Bridging
* Case 29-2003: A 60-Year-Old Man with Fever, Rigors, and Sweats
* Detection of SARS Coronavirus in Plasma by Real-Time RT-PCR
* Estimated Timing of the Last Common Ancestor of the SARS Coronavirus
*
Book Reviews
* Einstein's Luck: The Truth Behind Some of the Greatest Scientific Discoveries
* How to Win the Nobel Prize: An Unexpected Life in Science
* Stiff: The Curious Lives of Human Cadavers
Original Articles
Long-Term Effect of Doxazosin, Finasteride, or Both on the Clinical Progression of Benign Prostatic Hyperplasia

In this long-term trial, the combination of an alpha-blocker (doxazosin) and a 5{alpha}-reductase inhibitor (finasteride) was superior to either drug alone in retarding the clinical progression of benign prostatic hyperplasia.

Benign prostatic hyperplasia, a common disorder in men over the age of 60 years, can cause distressing symptoms and sometimes requires invasive treatment. The findings of this carefully conducted study may change the medical management of the disorder.

Related Editorial


Original Articles
Accelerated Atherosclerosis in Systemic Lupus Erythematosus

Patients with systemic lupus are at increased risk for myocardial infarction. In this study, the extent of carotid atherosclerosis was investigated by ultrasonography in patients with lupus and matched controls. Patients with lupus had premature atherosclerosis that was not related to traditional cardiovascular risk factors.

Premature atherosclerosis in lupus may be promoted by disease-related factors such as chronic inflammation. The findings in this study and that by Asanuma et al. (also in this issue of the Journal ) point to the need for interventions to prevent vascular disease in patients with lupus.

Related Perspective


Original Articles
Premature Coronary Atherosclerosis in Systemic Lupus Erythematosus

Coronary artery disease is an important cause of death in patients with systemic lupus. In this study, electron-beam computed tomography was used to assess coronary-artery calcification in patients with lupus and matched controls. Coronary calcification was more frequent and more extensive and occurred at a younger age in the patients than in the controls.

The findings could not be explained by traditional coronary risk factors. Novel approaches to the prevention of vascular disease in patients with lupus are needed.

Related Perspective


Original Articles
Transmission of SARS on Aircraft

This careful study is based on interviews of passengers and crew members on three flights that carried patients with the severe acute respiratory syndrome (SARS). Twenty-two persons became ill a mean of four days after one of the flights. The risk was highest among the passengers seated within three rows in front of the symptomatic index patient (relative risk, 3.1).

SARS became a global crisis because infected persons traveled on aircraft to many countries. Measures to reduce the risk of transmission are warranted.

Related Perspective


Health Policy Reports
The Academic–Industrial Alliance

This Health Policy Report reviews the history of the relationships between academic institutions and industrial organizations in the United States and discusses recent developments in this area. Academic–industrial relationships have fostered the development and dissemination of valuable medical advances, but they have also resulted in financial conflicts of interest that have threatened both the welfare of subjects enrolled in clinical research trials and the integrity of the research process. The author outlines strategies for managing academic–industrial relationships so as to safeguard both human subjects and the integrity of research.


Clinical Practice
Chlamydial Infection

A 19-year-old woman visits her primary care provider for counseling about contraception. She became sexually active one year earlier and has had a new sexual partner for the past three months. Her partner currently uses a condom intermittently. She reports no medical problems, and her physical examination is unremarkable. Is testing for Chlamydia trachomatis indicated?


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.